Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial

被引：0
|
作者：
Rennard, S. I. [1 ]
D'Urzo, A. D. [2 ]
Donohue, J. F. [3 ]
He, T. [4 ]
Shrestha, P. [4 ]
Leselbaum, A. [5 ]
Caracta, C. [4 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] Almirall SA, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6008
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    Anthony D D’Urzo
    Stephen I Rennard
    Edward M Kerwin
    Victor Mergel
    Anne R Leselbaum
    Cynthia F Caracta
    Respiratory Research, 15
  • [22] Overall And Cardiovascular Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination (fdc) In COPD: Pooled Analyses Of Four Phase Iii Studies
    Donohue, J. F.
    D'Urzo, A. D.
    Korn, S.
    Shrestha, P.
    Lei, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [23] Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD
    Singh, Dave
    Chapman, Kenneth
    Make, Barry
    Mocarski, Michelle
    Serra, Cristina
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [24] Overall and cardiovascular safety of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in patients with COPD
    Beier, Jutta
    Vogelmeier, Claus
    Mroz, Robert
    Pascual, Sergi
    Maria Segarra, Rosa
    Lei, Alejhandra
    De Miquel, Gonzalo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [25] Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
    Singh, Dave
    Jones, Paul W.
    Bateman, Eric D.
    Korn, Stephanie
    Serra, Cristina
    Molins, Eduard
    Caracta, Cynthia
    Gil, Esther Garcia
    Leselbaum, Anne
    BMC PULMONARY MEDICINE, 2014, 14
  • [26] Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
    Dave Singh
    Paul W Jones
    Eric D Bateman
    Stephanie Korn
    Cristina Serra
    Eduard Molins
    Cynthia Caracta
    Esther Garcia Gil
    Anne Leselbaum
    BMC Pulmonary Medicine, 14
  • [27] Safety of aclidinium bromide/formoterol fumarate fixed dose combination (FDC) in COPD: Pooled analyses of three phase III studies
    Korn, Stephanie
    Kerwin, Edward
    Donohue, James F.
    Shrestha, Pomy
    Leselbaum, Anne
    Lei, Alejhandra
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study
    Singh, Dave
    Jones, Paul
    Bateman, Eric
    Korn, Stephanie
    Serra, Cristina
    Molins, Eduard
    Caracta, Cynthia
    Gil, Esther Garcia
    Leselbaum, Anne
    CHEST, 2014, 145 (03)
  • [29] Efficacy of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in COPD
    Vogelmeier, Claus
    Paggiaro, Pier Luigi
    Dorca, Jordi
    Sliwinski, Pawel
    Mallet, Marcel
    Kirsten, Anne-Marie
    Seoane, Beatriz
    Maria Segarra, Rosa
    Leselbaum, Anne
    Garcia Gil, Esther
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [30] Dose-Ranging Study of 2 Fixed-Dose Combinations of Twice-Daily Aclidinium Bromide Plus Formoterol in Patients With Moderate to Severe COPD
    Kerwin, Edward
    Lapidus, Robert
    Leselbaum, Anne
    Ortiz, Stephan
    Rowe, Paul
    Caracta, Cynthia
    CHEST, 2013, 144 (04)
12345